Rep. Buddy Carter (R-GA) voted yes on 8 of 8 bills (100%) that an AI classifier identified as favoring his top donor sectors—Pharmaceuticals & Biotech and Retail & Consumer—ranking #2 among House members on this metric. He voted yes on the Medical Marijuana and Cannabidiol Research Expansion Act, classified as favoring pharmaceuticals, and voted yes on 3 of 4 bills classified as limiting those same sectors.

EXAMPLE VOTES BEHIND THE NUMBER
HR8454-117 — Medical Marijuana and Cannabidiol Research Expansion Act
HR3537-117 — Accelerating Access to Critical Therapies for ALS Act
S3580-117 — Ocean Shipping Reform Act of 2022
FOLLOW THE TRAIL
◈ Ask the Analyst about Earl L. "Buddy" Carter →How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated July 26, 2026 · internal signal score 90/100.